CRISPR THERAPEUTICS AG's ticker is CRSP and the CUSIP is H17182108. A total of 7 filers reported holding CRISPR THERAPEUTICS AG in Q4 2023. The put-call ratio across all filers is - and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $193,861 | -74.8% | 4,271 | -68.8% | 0.01% | -76.9% |
| Q2 2023 | $769,736 | +91317.6% | 13,711 | -26.3% | 0.03% | -3.7% |
| Q1 2023 | $842 | +510.1% | 18,615 | +448.1% | 0.03% | +350.0% |
| Q4 2022 | $138 | -100.0% | 3,396 | -87.4% | 0.01% | -79.3% |
| Q3 2022 | $1,763,000 | +62.5% | 26,990 | +51.1% | 0.03% | +20.8% |
| Q2 2022 | $1,085,000 | +162.7% | 17,862 | +171.9% | 0.02% | +500.0% |
| Q1 2022 | $413,000 | +76.5% | 6,570 | +113.0% | 0.00% | 0.0% |
| Q4 2021 | $234,000 | -28.2% | 3,085 | +5.9% | 0.00% | -50.0% |
| Q3 2021 | $326,000 | -83.3% | 2,912 | -75.9% | 0.01% | -84.3% |
| Q2 2021 | $1,953,000 | -64.8% | 12,061 | -73.5% | 0.05% | -45.2% |
| Q1 2021 | $5,552,000 | +997.2% | 45,570 | +1278.8% | 0.09% | +520.0% |
| Q4 2020 | $506,000 | +932.7% | 3,305 | +462.1% | 0.02% | +1400.0% |
| Q3 2020 | $49,000 | +172.2% | 588 | +142.0% | 0.00% | 0.0% |
| Q2 2020 | $18,000 | -71.0% | 243 | -76.1% | 0.00% | -80.0% |
| Q4 2019 | $62,000 | +3000.0% | 1,016 | +2061.7% | 0.01% | – |
| Q3 2019 | $2,000 | -85.7% | 47 | -83.7% | 0.00% | -100.0% |
| Q2 2019 | $14,000 | -65.9% | 288 | -74.9% | 0.00% | -50.0% |
| Q1 2019 | $41,000 | -95.6% | 1,148 | -96.5% | 0.00% | -97.0% |
| Q4 2018 | $929,000 | +1329.2% | 32,502 | +2103.5% | 0.07% | +1240.0% |
| Q3 2018 | $65,000 | +71.1% | 1,475 | +125.9% | 0.01% | +150.0% |
| Q2 2018 | $38,000 | -67.2% | 653 | -74.2% | 0.00% | -80.0% |
| Q1 2018 | $116,000 | +364.0% | 2,532 | +82.6% | 0.01% | +400.0% |
| Q3 2017 | $25,000 | +150.0% | 1,387 | +189.6% | 0.00% | +100.0% |
| Q4 2016 | $10,000 | – | 479 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Versant Venture Management, LLC | 3,608,874 | $160,053,562,000 | 54.44% |
| Abingworth LLP | 1,237,202 | $54,858,000 | 32.62% |
| NEA Management Company, LLC | 2,090,678 | $92,722,000 | 4.00% |
| New Leaf Venture Partners, L.L.C. | 444,708 | $19,723,000 | 3.59% |
| EcoR1 Capital, LLC | 500,000 | $22,175,000 | 2.00% |
| ARK Investment Management | 1,453,590 | $64,467,000 | 1.95% |
| CLOUGH CAPITAL PARTNERS L P | 337,731 | $14,978,000 | 1.41% |
| Casdin Capital, LLC | 220,000 | $9,757,000 | 1.19% |
| Valiant Capital Management, L.P. | 271,700 | $12,050,000 | 1.07% |
| Monashee Investment Management LLC | 110,000 | $4,879,000 | 1.03% |